SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, announced today that its Board of Directors has...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™...
Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic...
Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Jerome Adams, MD, MPH, will serve as a Strategic Healthcare Adviser to Lumos and...
HIGHLIGHTS Annual revenues of A$25.0 million, up 198% from FY20 Commercial Services business unit delivered $22.7 million in revenues, up 188% from FY20 Products business unit generated revenue...
Global, innovative rapid point-of-care diagnostic company plans expansion and commercialization of suite of diagnostic products following ASX IPO Rapid, point-of-care (POC) diagnostics company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.002 | 5.26315789474 | 0.038 | 0.043 | 0.036 | 1630294 | 0.03727004 | DE |
4 | -0.003 | -6.97674418605 | 0.043 | 0.043 | 0.031 | 5556549 | 0.03454142 | DE |
12 | -0.003 | -6.97674418605 | 0.043 | 0.054 | 0.031 | 2717790 | 0.0384428 | DE |
26 | -0.02 | -33.3333333333 | 0.06 | 0.069 | 0.028 | 2737757 | 0.04148196 | DE |
52 | -0.056 | -58.3333333333 | 0.096 | 0.1075 | 0.028 | 4726941 | 0.07108889 | DE |
156 | -0.84 | -95.4545454545 | 0.88 | 1.265 | 0.01 | 4009819 | 0.08794305 | DE |
260 | -1.46 | -97.3333333333 | 1.5 | 1.5 | 0.01 | 3713541 | 0.09721769 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.